{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:03:30Z","timestamp":1787169810443,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014513","name":"Universitetet i Stavanger","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bmcl.2025.130426","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:14:48Z","timestamp":1759796088000},"page":"130426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro comparison of the glycosidase inhibitory profile of isoiminosugars with their 1- and 5a-modified derivatives"],"prefix":"10.1016","volume":"130","author":[{"given":"Solveig Auranaune","family":"Markussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Lindb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130426_bb0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1039\/B915870G","article-title":"Glycosidase inhibition: assessing mimicry of the transition state","volume":"8","author":"Gloster","year":"2010","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0010","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1039\/D3CS00032J","article-title":"Glycosidase-targeting small molecules for biological and therapeutic applications","volume":"52","author":"Kim","year":"2023","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2025.130426_bb0015","doi-asserted-by":"crossref","first-page":"D233","DOI":"10.1093\/nar\/gkn663","article-title":"The carbohydrate-active EnZymes database (CAZy): an expert resource for Glycogenomics","volume":"37","author":"Cantarel","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-385518-3.00004-3","article-title":"Imino sugars and glycosyl hydrolases: historical context, current aspects, emerging trends","volume":"66","author":"St\u00fctz","year":"2011","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0025","series-title":"Comprehensive Glycoscience-From Chemistry to Systems Biology","first-page":"815","article-title":"Glycosidase inhibitors: Structure, activity, synthesis, and medical relevance","author":"Bols","year":"2007"},{"key":"10.1016\/j.bmcl.2025.130426_bb0030","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1351\/pac199668101919","article-title":"Nomenclature of carbohydrates (IUPAC recommendations 1996)","volume":"68","author":"McNaught","year":"1996","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2010.08.017","article-title":"Iminosugars past, present and future: medicines for tomorrow","volume":"16","author":"Horne","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2025.130426_bb0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bioorg.2019.03.053","article-title":"Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes","volume":"87","author":"Ferhati","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106147","article-title":"\u03b1-Glucosidase inhibitors as broad-spectrum antivirals: current knowledge and future prospects","volume":"238","author":"Kang","year":"2025","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0050","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C6CC01564F","article-title":"Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases","volume":"52","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmcl.2025.130426_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/BST20160182","article-title":"Iminosugar antivirals: the therapeutic sweet spot","volume":"45","author":"Alonzi","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bmcl.2025.130426_bb0060","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/acs.jmedchem.2c01750","article-title":"Structure-based design of potent iminosugar inhibitors of endoplasmic reticulum \u03b1-glucosidase I with anti-SARS-CoV-2 activity","volume":"66","author":"Karade","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/jac\/dku349","article-title":"Strain-specific antiviral activity of iminosugars against human influenza a viruses","volume":"70","author":"Hussain","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2025.130426_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.21686","article-title":"Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus","volume":"46","author":"Steinmann","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bmcl.2025.130426_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104881","article-title":"Iminosugars: a host-targeted approach to combat Flaviviridae infections","volume":"184","author":"Evans DeWald","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0080","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bmcl.2025.130426_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bmcl.2025.130426_bb0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/biom13081227","article-title":"Therapeutic role of pharmacological chaperones in lysosomal storage disorders: a review of the evidence and informed approach to reclassification","volume":"13","author":"Keyzor","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmcl.2025.130426_bb0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase a in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2025.130426_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.bmcl.2025.130426_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/13543784.12.2.273","article-title":"Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1","volume":"12","author":"Pastores","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bmcl.2025.130426_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/14656566.1.1.149","article-title":"Miglitol, a new \u03b1-glucosidase inhibitor","volume":"1","author":"Sels","year":"1999","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bmcl.2025.130426_bb0115","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3390\/molecules25122843","article-title":"Strategy for designing selective lysosomal acid \u03b1-glucosidase inhibitors: binding orientation and influence on selectivity","volume":"25","author":"Kato","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130426_bb0120","series-title":"Carbohydrates as Drugs","first-page":"23","article-title":"Iminosugars: Therapeutic applications and synthetic considerations","author":"Horne","year":"2014"},{"key":"10.1016\/j.bmcl.2025.130426_bb0125","first-page":"288","article-title":"The structure of nojirimycin, a piperidinose sugar antibiotic","volume":"19","author":"Inouye","year":"1966","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2025.130426_bb0130","series-title":"Adv Carbohydr Chem Biochem","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0065-2318(08)60034-7","article-title":"Glycoside hydrolases: Mechanistic information from studies with reversible and irreversible inhibitors","volume":"Vol. 48","author":"Legler","year":"1990"},{"key":"10.1016\/j.bmcl.2025.130426_bb0135","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1080\/00021369.1970.10859713","article-title":"\u201cNojirimycin\u201d as a potent inhibitor of glucosidase","volume":"34","author":"Niwa","year":"1970","journal-title":"Agric Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0140","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ja066961g","article-title":"Glycosidase inhibition: an assessment of the binding of 18 putative transition-state mimics","volume":"129","author":"Gloster","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0145","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1016\/j.bmc.2013.03.003","article-title":"Enzyme inhibition by iminosugars: analysis and insight into the glycosidase\u2013iminosugar dependency of pH","volume":"21","author":"L\u00f3pez","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0150","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1021\/bi00335a022","article-title":"Reversible inhibitors of \u03b2-glucosidase","volume":"24","author":"Dale","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2025.130426_bb0155","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1021\/jo201125x","article-title":"Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells","volume":"76","author":"Diot","year":"2011","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0160","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.bmc.2011.04.011","article-title":"Docking and SAR studies of D- and L-isofagomine isomers as human \u03b2-glucocerebrosidase inhibitors","volume":"19","author":"Kato","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ar970058r","article-title":"1-Aza sugars, apparent transition state analogues of equatorial glycoside formation\/cleavage","volume":"31","author":"Bols","year":"1998","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0170","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6","article-title":"Recent insights into inhibition, structure, and mechanism of configuration-retaining glycosidases","volume":"38","author":"Heightman","year":"1999","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.bmcl.2025.130426_bb0175","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1039\/C7SC01540B","article-title":"Determination of protonation states of iminosugar\u2013enzyme complexes using photoinduced electron transfer","volume":"8","author":"Wang","year":"2017","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmcl.2025.130426_bb0180","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1039\/c39850001669","article-title":"A new class of fluorescent pH indicators based on photo-induced electron transfer","volume":"23","author":"de Silva","year":"1985","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1016\/j.bmcl.2025.130426_bb0185","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.1002\/anie.202002850","article-title":"Imino- and azasugar protonation inside human acid \u03b2-glucosidase, the enzyme that is defective in Gaucher disease","volume":"59","author":"Matassini","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130426_bb0190","first-page":"1637","article-title":"Energy of binding of aspergillus oryzae beta-glucosidase with the substrate, and the mechanism of its enzymic action","volume":"94","author":"Mega","year":"1983","journal-title":"J Biochem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0195","doi-asserted-by":"crossref","first-page":"16194","DOI":"10.1021\/bi00049a035","article-title":"Mechanism of Agrobacterium \u03b2-glucosidase: kinetic analysis of the role of noncovalent enzyme\/substrate interactions","volume":"34","author":"Namchuk","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2025.130426_bb0200","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1021\/ja001762x","article-title":"A large difference in the thermodynamics of binding of isofagomine and 1-deoxynojirimycin to \u03b2-glucosidase","volume":"122","author":"B\u00fclow","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0205","doi-asserted-by":"crossref","first-page":"14313","DOI":"10.1021\/ja036833h","article-title":"Iminosugar glycosidase inhibitors: structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to \u03b2-glucosidases","volume":"125","author":"Zechel","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0210","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/anie.199417781","article-title":"Isofagomine, a potent, new glycosidase inhibitor","volume":"33","author":"Jespersen","year":"1994","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.bmcl.2025.130426_bb0215","doi-asserted-by":"crossref","first-page":"13449","DOI":"10.1016\/S0040-4020(01)89351-0","article-title":"Synthesis of isofagomine, a novel glycosidase inhibitor","volume":"50","author":"Jespersen","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2025.130426_bb0220","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/1521-3773(20010917)40:18<3447::AID-ANIE3447>3.0.CO;2-8","article-title":"A free-energy relationship between the rate of acidic hydrolysis of glycosides and the pKa of isofagomines","volume":"40","author":"Jensen","year":"2001","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130426_bb0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/cr000433k","article-title":"Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin","volume":"102","author":"Lillelund","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2025.130426_bb0230","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/0040-4039(95)00870-I","article-title":"An extremely potent inhibitor for \u03b2-galactosidase","volume":"36","author":"Ichikawa","year":"1995","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0960-894X(96)00068-6","article-title":"Synthesis of a new inhibitor of \u03b1-fucosidase","volume":"6","author":"Igarashi","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0240","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/ja973443k","article-title":"1-N-Iminosugars: potent and selective inhibitors of \u03b2-glycosidases","volume":"120","author":"Ichikawa","year":"1998","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/ar970172","article-title":"Glycosidase mechanisms: anatomy of a finely tuned catalyst","volume":"33","author":"Zechel","year":"2000","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0250","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1039\/C5SC00754B","article-title":"Azasugar inhibitors as pharmacological chaperones for Krabbe disease","volume":"6","author":"Hill","year":"2015","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmcl.2025.130426_bb0255","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1021\/ja034917k","article-title":"Direct observation of the protonation state of an imino sugar glycosidase inhibitor upon binding","volume":"125","author":"Varrot","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0260","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1039\/C5OB00624D","article-title":"A fluorescence study of isofagomine protonation in \u03b2-glucosidase","volume":"13","author":"Lindb\u00e4ck","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0265","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1016\/S0040-4039(99)00423-2","article-title":"Synthesis of an 1-azaglucose analogue with ring-oxygen retained","volume":"40","author":"Bach","year":"1999","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0270","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/chem.19970030616","article-title":"1-Azafagomine: a hydroxyhexahydropyridazine that potently inhibits enzymatic glycoside cleavage","volume":"3","author":"Bols","year":"1997","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2025.130426_bb0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1521-3765(20000117)6:2<278::AID-CHEM278>3.0.CO;2-6","article-title":"Enantiospecific synthesis of 1-azafagomine","volume":"6","author":"Ernholt","year":"2000","journal-title":"Chem Eur J"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130426_bb0280","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1039\/b007973l","article-title":"Synthesis of 1-azagalactofagomine, a potent galactosidase inhibitor","volume":"1","author":"Jensen","year":"2001","journal-title":"J Chem Soc Perkin Trans"},{"key":"10.1016\/j.bmcl.2025.130426_bb0285","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2015.08.038","article-title":"Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp2-iminosugar conjugates against glycosidases: a structure\u2013activity relationship study in Gaucher fibroblasts","volume":"121","author":"Mena-Barrag\u00e1n","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0290","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1021\/jm0495881","article-title":"Biological properties of d- and l-1-deoxyazasugars","volume":"48","author":"Kato","year":"2005","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130426_bb0295","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1039\/b200884j","article-title":"Synthesis and investigation of L-fuco- and D-glucurono-azafagomine","volume":"1","author":"Jensen","year":"2002","journal-title":"J Chem Soc Perkin Trans"},{"key":"10.1016\/j.bmcl.2025.130426_bb0300","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1021\/ja010240u","article-title":"Noeuromycin, a glycosyl cation mimic that strongly inhibits glycosidases","volume":"123","author":"Liu","year":"2001","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0305","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1039\/b208784g","article-title":"Isofagomine lactams, synthesis and enzyme inhibition","volume":"1","author":"Lillelund","year":"2003","journal-title":"Org Biomol Chem"},{"issue":"14","key":"10.1016\/j.bmcl.2025.130426_bb0310","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1039\/b103831c","article-title":"A neutral nanomolar galactosidase inhibitor","volume":"1","author":"S\u00f8hoel","year":"2001","journal-title":"J Chem Soc Perkin Trans"},{"key":"10.1016\/j.bmcl.2025.130426_bb0315","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/cbic.200400169","article-title":"Common inhibition of both \u03b2-glucosidases and \u03b2-mannosidases by isofagomine lactam reflects different conformational itineraries for pyranoside hydrolysis","volume":"5","author":"Vincent","year":"2004","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0320","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/1522-2675(20000705)83:7<1599::AID-HLCA1599>3.0.CO;2-0","article-title":"Sugar-derived di- and tetrahydropyridazinones: synthesis of new glycosidase inhibitors","volume":"83","author":"Venkata Ramana","year":"2000","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.bmcl.2025.130426_bb0325","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1021\/ja0002870","article-title":"A new, simple, high-affinity glycosidase inhibitor: analysis of binding through X-ray crystallography, mutagenesis, and kinetic analysis","volume":"122","author":"Williams","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0330","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1021\/ja00172a045","article-title":"Potent, broad-spectrum inhibition of glycosidases by an amidine derivative of D-glucose","volume":"112","author":"Tong","year":"1990","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0335","doi-asserted-by":"crossref","first-page":"11682","DOI":"10.1021\/ja00078a004","article-title":"Amidine, amidrazone, and amidoxime derivatives of monosaccharide aldonolactams: synthesis and evaluation as glycosidase inhibitors","volume":"115","author":"Papandreou","year":"1993","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0340","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2174\/0929867329666211222164545","article-title":"Sugar-derived amidines and congeners: structures, glycosidase inhibition and applications","volume":"29","author":"Bl\u00e9riot","year":"2022","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0345","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/ol200942g","article-title":"An isofagomine analogue with an amidine at the pseudoanomeric position","volume":"13","author":"Lindb\u00e4ck","year":"2011","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0350","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.241877","article-title":"An isofagomine analogue with an amidine group in the 1,6-position","volume":"12","author":"Vaaland Holmgard","year":"2025","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.bmcl.2025.130426_bb0355","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/jacs.8b02399","article-title":"Gluco-1 H-imidazole: a new class of azole-type \u03b2-glucosidase inhibitor","volume":"140","author":"Schr\u00f6der","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130426_bb0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/ph12030108","article-title":"Iminosugars: effects of stereochemistry, ring size, and N-substituents on glucosidase activities","volume":"12","author":"Zamoner","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2025.130426_bb0365","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.bmcl.2025.130426_bb0370","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1074\/jbc.M705005200","article-title":"Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid \u03b2-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease","volume":"282","author":"Brumshtein","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0375","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1016\/j.bmc.2006.08.003","article-title":"Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease","volume":"14","author":"Yu","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0380","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1016\/j.bmcl.2004.09.086","article-title":"\u03b1-1-C-alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile","volume":"14","author":"Godin","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0385","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0960-894X(97)00012-7","article-title":"New deoxynojirimycin derivatives as potent inhibitors of intestinal \u03b1-glucohydrolases","volume":"7","author":"Lesur","year":"1997","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0390","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.carres.2016.01.006","article-title":"Influence of the configurational pattern of sp2-iminosugar pseudo N-, S-, O- and C-glycosides on their glycoside inhibitory and antitumor properties","volume":"429","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0395","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bcp.2003.09.036","article-title":"Inhibition of glycogen breakdown by imino sugars in vitro and in vivo","volume":"67","author":"Andersson","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130426_bb0400","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.bmcl.2006.01.095","article-title":"Fluorescent glycosidase inhibiting 1,5-dideoxy-1,5-iminoalditols","volume":"16","author":"Greimel","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0405","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1002\/anie.200502662","article-title":"Rational design and synthesis of highly potent \u03b2-glucocerebrosidase inhibitors","volume":"44","author":"Zhu","year":"2005","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130426_bb0410","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/cbic.201100332","article-title":"Synthesis, kinetic evaluation and cell-based analysis of C-alkylated isofagomines as chaperones of \u03b2-glucocerebrosidase","volume":"12","author":"Hill","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0415","article-title":"A remarkable change in inhibition potency and selectivity of isofagomine by simple N-modification","author":"Culum","year":"2024","journal-title":"Monatsh Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0420","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/S0040-4039(99)00317-2","article-title":"The first combinatorial library of azasugar glycosidase inhibitors","volume":"40","author":"Lohse","year":"1999","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0425","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1055\/s-0039-1690019","article-title":"Bicyclic 1-azafagomine derivatives: synthesis and glycosidase inhibitory testing","volume":"51","author":"Evangelista","year":"2019","journal-title":"Synthesis"},{"key":"10.1016\/j.bmcl.2025.130426_bb0430","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cbic.200700012","article-title":"Anomer-selective glycosidase inhibition by 2-N-alkylated 1-azafagomines","volume":"8","author":"Lopez Lopez","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0435","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/jo201486q","article-title":"Advances in the synthesis of homochiral (\u2212)-1-azafagomine and (+)-5-epi-1-azafagomine. 1-N-phenyl carboxamide derivatives of both enantiomers of 1-azafagomine: leads for the synthesis of active \u03b1-glycosidase inhibitors","volume":"76","author":"Alves","year":"2011","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.carres.2014.06.015","article-title":"Synthesis and evaluation of \u03b1-, \u03b2-glucosidase inhibition of 1-N-carboxamide-1-azafagomines and 5-epi-1-azafagomines","volume":"395","author":"Mendes","year":"2014","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0445","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1081\/CAR-200030070","article-title":"Synthesis and chemistry of noeuromycin and isofagomine analogues","volume":"23","author":"Liu","year":"2004","journal-title":"J Carbohydr Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0450","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/B918576C","article-title":"Synthesis and glycosidase inhibitory activity of noeurostegine\u2014a new and potent inhibitor of \u03b2-glucoside hydrolases","volume":"8","author":"Rasmussen","year":"2010","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0455","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bmcl.2010.12.106","article-title":"Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher\u2019s disease","volume":"21","author":"Rasmussen","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0460","first-page":"684","article-title":"N-alkyl isofagomine lactams: synthesis, glycosidase inhibition, and antimicrobial assessments","volume":"57","author":"More\u0144","year":"2024","journal-title":"Synthesis"},{"key":"10.1016\/j.bmcl.2025.130426_bb0465","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cmdc.201500485","article-title":"N-alkyl-, 1-C-alkyl-, and 5-C-alkyl-1,5-dideoxy-1,5-imino-(l)-ribitols as galactosidase inhibitors","volume":"11","author":"Front","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0470","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.09.095","article-title":"(5aR)-5a-C-pentyl-4-epi-isofagomine: a powerful inhibitor of lysosomal \u03b2-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B","volume":"126","author":"Front","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0475","doi-asserted-by":"crossref","first-page":"14560","DOI":"10.1074\/jbc.M113.529529","article-title":"Structural basis of pharmacological chaperoning for human \u03b2-galactosidase","volume":"289","author":"Suzuki","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.carres.2016.03.020","article-title":"Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable \u03b2-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal \u03b2-galactosidase mutant R201C","volume":"429","author":"Thonhofer","year":"2016","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmcl.2025.130426_bb0485","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bmcl.2016.01.059","article-title":"Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: powerful \u03b2-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal \u03b2-galactosidase","volume":"26","author":"Thonhofer","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130426_bb0490","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1039\/C6OB01309K","article-title":"Synthesis and evaluation of N-alkylated analogues of aza-galacto-fagomine\u2014potential pharmacological chaperones for Krabbe disease","volume":"14","author":"Viuff","year":"2016","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2025.130426_bb0495","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2298\/JSC240315062D","article-title":"Alkylated analogues of aza-galactofagomine as potential inhibitors of \u03b2-glucosidase","volume":"89","author":"Djurkovic","year":"2024","journal-title":"J Serb Chem Soc."}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500335X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500335X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T08:16:21Z","timestamp":1761639381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500335X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":99,"alternative-id":["S0960894X2500335X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130426","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro comparison of the glycosidase inhibitory profile of isoiminosugars with their 1- and 5a-modified derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130426"}}